blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3836949

EP3836949 - COMPOSITIONS COMPRISING SEL1-DERIVED PEPTIDES AND METHODS OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS AND ASSOCIATED CONDITIONS/DISEASES THEREWITH [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  15.12.2023
Database last updated on 07.10.2024
FormerRequest for examination was made
Status updated on  21.05.2021
FormerThe international publication has been made
Status updated on  25.01.2020
Most recent event   Tooltip12.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
The University of Chicago
5801 South Ellis Avenue Chicago
Illinois 60637 / US
[2021/25]
Inventor(s)01 / HASSAN, Hatim A.
c/o The University of Chicago 5801 S. Ellis
Avenue
Chicago, Illinois 60637 / US
02 / ARVANS, Donna
c/o The University of Chicago 5801 S. Ellis
Avenue
Chicago, Illinois 60637 / US
 [2021/25]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[2021/25]
Application number, filing date19838795.318.07.2019
[2021/25]
WO2019US42416
Priority number, dateUS201862699975P18.07.2018         Original published format: US 201862699975 P
[2021/25]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020018799
Date:23.01.2020
Language:EN
[2020/04]
Type: A1 Application with search report 
No.:EP3836949
Date:23.06.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 23.01.2020 takes the place of the publication of the European patent application.
[2021/25]
Search report(s)International search report - published on:US23.01.2020
(Supplementary) European search report - dispatched on:EP04.02.2022
ClassificationIPC:A61K38/00, A61K38/16, A61K39/02, C07K14/47
[2022/10]
CPC:
C07K14/47 (EP); A61K38/164 (US); A61P13/04 (US);
A61P7/08 (US); A61K38/00 (EP)
Former IPC [2021/25]A61K38/00, A61K38/16, A61K39/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/25]
TitleGerman:ZUSAMMENSETZUNGEN MIT SEL1-ABGELEITETEN PEPTIDEN UND VERFAHREN ZUR BEHANDLUNG/PRÄVENTION VON ZU HOHEN OXALATSPIEGELN UND DAMIT EINHERGEHENDEN ERKRANKUNGEN[2021/25]
English:COMPOSITIONS COMPRISING SEL1-DERIVED PEPTIDES AND METHODS OF TREATMENT/PREVENTION OF EXCESS OXALATE LEVELS AND ASSOCIATED CONDITIONS/DISEASES THEREWITH[2021/25]
French:COMPOSITIONS COMPRENANT DES PEPTIDES DÉRIVÉS DE SEL1 ET MÉTHODES DE TRAITEMENT/PRÉVENTION DE TAUX D'OXALATE EN EXCÈS ET PATHOLOGIES/MALADIES ASSOCIÉS À CEUX-CI[2021/25]
Entry into regional phase22.01.2021National basic fee paid 
22.01.2021Search fee paid 
22.01.2021Designation fee(s) paid 
22.01.2021Examination fee paid 
Examination procedure22.01.2021Examination requested  [2021/25]
05.09.2022Amendment by applicant (claims and/or description)
18.12.2023Despatch of a communication from the examining division (Time limit: M04)
18.04.2024Reply to a communication from the examining division
Fees paidRenewal fee
15.07.2021Renewal fee patent year 03
15.06.2022Renewal fee patent year 04
14.06.2023Renewal fee patent year 05
12.06.2024Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[IA]US6200562  (ALLISON MILTON J [US], et al);
 [I]WO2005097176  (UNIV FLORIDA [US], et al);
 [I]US2014030324  (SIDHU HARMEET [US], et al);
 [I]EP3016669  (OXTHERA INTELLECTUAL PROPERTY AB [SE]);
 [XP]WO2018136779  (UNIV CHICAGO [US]);
International search[Y]US2012308600  (COSTANTINO PAOLO [IT], et al);
by applicantUS5359030
 US5681811
 US6200562
 US6552167
 WO2005097176
 US2014030324
 WO2015002604
 EP3016669
 WO2018136779
 WO2018US14494
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.